|
Cutaneous Drug Reactions
|
|
Drug Reactions, Cutaneous; Skin Disorders, Drug Reactions
|
Cutaneous Drug Reactions Clinical Trials
- Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides
ClinicalTrials.gov Identifier: NCT00002557 - Active, not recruiting
stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma
- Bexarotene and Interferon alfa in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00030849 - Active, not recruiting
stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; ...
- Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
ClinicalTrials.gov Identifier: NCT00317980 - Active, not recruiting
Cutaneous Leishmaniasis
- Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00030589 - Active, not recruiting
stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ...
- Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
ClinicalTrials.gov Identifier: NCT00537953 - Recruiting
Cutaneous Leihmaniasis
- Adverse Drug Reactions of Different Brands of Ceftazidime Injection
ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
Infection
- Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia
ClinicalTrials.gov Identifier: NCT00233545 - Active, not recruiting
Cutaneous Leishmaniasis
- Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00098332 - Active, not recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- O(6)-benzylguanine and Carmustine in Treating Patients With Stage I or Stage II Cutaneous T-cell Lymphoma
ClinicalTrials.gov Identifier: NCT00003613 - Active, not recruiting
stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ...
- Blood and Tissue Collection for Cutaneous Lymphoma Research
ClinicalTrials.gov Identifier: NCT00177268 - Recruiting
Cutaneous T-Cell Lymphoma; Sezary Syndrome; Mycosis Fungoides
- Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
ClinicalTrials.gov Identifier: NCT00317629 - Recruiting
Cutaneous Leishmaniasis
- BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00061880 - Active, not recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- CpG 7909 in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00091208 - Active, not recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis
ClinicalTrials.gov Identifier: NCT00469495 - Recruiting
Leishmaniasis, Cutaneous; Helminthiasis
- National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children
ClinicalTrials.gov Identifier: NCT00414115 - Recruiting
Adverse Drug Reaction (ADR)
- Evaluation of Efficacy and Safety of Miltefosine for Cutaneous Leishmaniasis in Colombia
ClinicalTrials.gov Identifier: NCT00471705 - Recruiting
Cutaneous Leishmaniasis
- Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
ClinicalTrials.gov Identifier: NCT00487253 - Recruiting
Cutaneous Leishmaniasis
- Pathogenesis of Adverse Drug Reactions
ClinicalTrials.gov Identifier: NCT00224952 - Recruiting
Seizures
- An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients
ClinicalTrials.gov Identifier: NCT00127101 - Recruiting
Cutaneous T-Cell Lymphoma
- A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00476554 - Recruiting
Cutaneous T-Cell Lymphoma (CTCL)
- Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser
ClinicalTrials.gov Identifier: NCT00523588 - Recruiting
Cutaneous Lupus Erythematosus
- Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin
ClinicalTrials.gov Identifier: NCT00066664 - Recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma-2212
ClinicalTrials.gov Identifier: NCT00490776 - Recruiting
Cutaneous T-Cell Lymphoma
- Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00182637 - Recruiting
Cutaneous T-Cell Lymphoma; Mycosis Fungoides and Sezary Syndrome
- Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00425555 - Recruiting
Cutaneous T-Cell Lymphoma
- Multiphoton Laser Scanning Microscopy in Cutaneous Optical Pathology
ClinicalTrials.gov Identifier: NCT00508781 - Recruiting
Optical Biopsy; Cutaneous Pathology; Dermatopathology
- Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis
ClinicalTrials.gov Identifier: NCT00257530 - Not yet recruiting
Cutaneous Leishmaniasis
- Compassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00419367 - Recruiting
Lymphoma, T-Cell, Cutaneous
- A Single Agent Phase II Study of Depsipeptide (FK228) in the Treatment of Cutaneous T-cell Lymphoma
ClinicalTrials.gov Identifier: NCT00106431 - Recruiting
Cutaneous T-Cell Lymphoma
- Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas
ClinicalTrials.gov Identifier: NCT00080535 - Recruiting
Lymphoma; T-Cell; Cutaneous
- A Study of APO866 for the Treatment of Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00431912 - Recruiting
Cutaneous T-Cell Lymphoma
- LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00412997 - Recruiting
Tumors; Cutaneous T-Cell Lymphoma
- Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
ClinicalTrials.gov Identifier: NCT00221039 - Recruiting
Cutaneous T Cell Lymphoma; Mycosis Fungoides
- Characterizing Serum Protein Patterns in Selected Skin Diseases
ClinicalTrials.gov Identifier: NCT00063167 - Recruiting
Psoriasis; Cutaneous T-Cell Lymphoma; Healthy
- Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants
ClinicalTrials.gov Identifier: NCT00001906 - Completed
Cutaneous Leishmaniasis
- Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
ClinicalTrials.gov Identifier: NCT00480883 - Recruiting
Leishmaniasis, Cutaneous
- Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00060385 - Active, not recruiting
adult T-cell leukemia and lymphoma; Cutaneous T-Cell Lymphoma; Non-Hodgkin's Lymphoma
- Interleukin-2 in Treating Patients With Mycosis Fungoides
ClinicalTrials.gov Identifier: NCT00002687 - Active, not recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- Origin and Course of Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00075322 - Recruiting
Cutaneous T-Cell Lymphoma
- Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
ClinicalTrials.gov Identifier: NCT00004106 - Active, not recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00554827 - Recruiting
Relapsed or Refractory Cutaneous T-Cell Lymphoma
- Cutaneous Effects of Cryogen Spray Cooling
ClinicalTrials.gov Identifier: NCT00581568 - Enrolling by invitation
Healthy
- Prevalence of Phonophobia and Cutaneous Allodynia in Episodic Migraineurs
ClinicalTrials.gov Identifier: NCT00386880 - Active, not recruiting
Migraine
- European Society of Cutaneous Lupus Erythematosus (EUSCLE)
ClinicalTrials.gov Identifier: NCT00420121 - Not yet recruiting
Systemic or Cutaneous Lupus Erythematosus
- Monoclonal Antibody SGN-30 in Treating Patients with Recurrent Or Refractory Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00118079 - Recruiting
recurrent cutaneous T-cell lymphoma; anaplastic large cell lymphoma
- Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome
ClinicalTrials.gov Identifier: NCT00002479 - Completed
stage II cutaneous T-cell lymphoma; stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; stage I cutaneous T-cell lymphoma
- Immunization Against Tumor Cells in Sezary Syndrome
ClinicalTrials.gov Identifier: NCT00099593 - Recruiting
Cutaneous T-Cell Lymphoma; Sezary Syndrome
- Pegfilgrastim Compared With Filgrastim To Increase Peripheral Stem Cells Before Autologous Stem Cell Transplantation in Treating Patients With Lymphoma
ClinicalTrials.gov Identifier: NCT00060229 - Active, not recruiting
adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma; Cutaneous T-Cell Lymphoma
- Cutaneous Lupus Erythematosus and Elidel
ClinicalTrials.gov Identifier: NCT00222183 - Recruiting
Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00053105 - Active, not recruiting
recurrent adult diffuse large cell lymphoma; recurrent grade III follicular large cell lymphoma; recurrent cutaneous T-cell lymphoma; ...
- Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer
ClinicalTrials.gov Identifier: NCT00198276 - Active, not recruiting
Cancer
- ONTAK to Estimate Response in Cutaneous T-Cell Lymphoma According to CD25 Status
ClinicalTrials.gov Identifier: NCT00279396 - Active, not recruiting
Non-Hodgkin's Lymphoma
- Surveillance for Leishmaniasis Skin Lesions in Mali
ClinicalTrials.gov Identifier: NCT00344084 - Active, not recruiting
Cutaneous Leishmaniasis
- Depsipeptide to Treat T-Cell Lymphomas
ClinicalTrials.gov Identifier: NCT00007345 - Recruiting
Cutaneous T Cell Lymphoma; Peripheral T Cell Lymphoma
- Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome
ClinicalTrials.gov Identifier: NCT00057967 - Recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- Molecular Epidemiology of Cutaneous Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00341991 - Active, not recruiting
Melanoma
- Study of the Cutaneous Microcirculation in Elderly People
ClinicalTrials.gov Identifier: NCT00266071 - Not yet recruiting
Elderly People
- Clinical Trial of HuMax-CD4, a new drug to treat Advanced Stage T-Cell Lymphoma in the skin.
ClinicalTrials.gov Identifier: NCT00071084 - Completed
Cutaneous T-Cell Lymphoma
- Clinical Trial of HuMax-CD4, a new drug to treat Early Stage T-Cell Lymphoma in the skin.
ClinicalTrials.gov Identifier: NCT00071071 - Completed
Cutaneous T-Cell Lymphoma
- Aminocamptothecin in Treating Patients With T-cell Lymphoma
ClinicalTrials.gov Identifier: NCT00002635 - Completed
stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma
- Anorexia in Children With Burn Injury and the Reactions of the Immune and Endocrine Systems
ClinicalTrials.gov Identifier: NCT00369876 - Active, not recruiting
Burns; Anorexia
- Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
ClinicalTrials.gov Identifier: NCT00074087 - Recruiting
stage II mycosis fungoides/Sezary syndrome; stage IV mycosis fungoides/Sezary syndrome; recurrent mycosis fungoides/Sezary syndrome; ...
- Post-Marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
ClinicalTrials.gov Identifier: NCT00304265 - Active, not recruiting
Pertussis; Diphtheria; Tetanus; Poliomyelitis
- Spectral Diagnosis of Cutaneous Malignancy
ClinicalTrials.gov Identifier: NCT00476905 - Recruiting
Skin Cancer
- Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas
ClinicalTrials.gov Identifier: NCT00374335 - Recruiting
Hemangioma
- Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
ClinicalTrials.gov Identifier: NCT00103246 - Recruiting
actinic keratosis; Cutaneous T-Cell Lymphoma; Skin Cancer
- A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00369512 - Recruiting
Cancer
- The Effect Of Light Emitting Diodes On Scar Appearance
ClinicalTrials.gov Identifier: NCT00544635 - Recruiting
Cutaneous Scars
- Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
ClinicalTrials.gov Identifier: NCT00461721 - Recruiting
Allergy
- FR901228 in Treating Patients With T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00020436 - Recruiting
adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite.
ClinicalTrials.gov Identifier: NCT00121849 - Completed
Cutaneous Leishmaniasis
- Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) with Yttrium-90 Radiolabeled Anti-Tac
ClinicalTrials.gov Identifier: NCT00001249 - Completed
Leukemia, T-Cell; Lymphoma, T-Cell, Cutaneous
- Effect of Denileukin Diftitox on Immune System in CTCL Patients
ClinicalTrials.gov Identifier: NCT00254332 - Recruiting
Cutaneous T-Cell Lymphoma; Sezary Syndrome; Mycosis Fungoides
- Phase I/II Study of Tac-Expressing Malignancies [Other than Adult T-Cell Leukemia (ATL)] with Yttrium-90 Radiolabeled Humanized Anti-Tac and Calcium-DTPA
ClinicalTrials.gov Identifier: NCT00001575 - Recruiting
Cutaneous T Cell Lymphoma; Hodgkin's Disease; Neoplasm; Non Hodgkin's Lymphoma; Peripheral T Cell Lymphoma
- Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain
ClinicalTrials.gov Identifier: NCT00306020 - Recruiting
Ulcer; Wounds and Injuries
- Training Compensatory Stepping and Grasping Reactions for Falls Prevention
ClinicalTrials.gov Identifier: NCT00187317 - Active, not recruiting
Accidental Falls
- Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00255801 - Recruiting
Lymphoma
- LMB-2 Immunotoxin in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00085085 - Recruiting
Lymphoma
- Cutaneous Denervation in Alcoholic Neuropathy
ClinicalTrials.gov Identifier: NCT00190073 - Recruiting
Alcohol Abuse; Peripheral Neuropathy
- Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00563823 - Recruiting
Melanoma (Skin)
- Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00430053 - Recruiting
Lymphoma
- Treatment of Cutaneous Ulcers With a Novel Biological Dressing
ClinicalTrials.gov Identifier: NCT00207818 - Recruiting
Venous Ulcers
- Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00506129 - Recruiting
Lymphoma
- In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)
ClinicalTrials.gov Identifier: NCT00177190 - Completed
Cutaneous T-Cell Lymphoma; Sezary Syndrome; Mycosis Fungoides
- Depsipeptide in Treating Patients With Solid Tumors
ClinicalTrials.gov Identifier: NCT00019318 - Completed
stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; ...
- To Study the Peripheral Effect of Botulinum Toxin-A (Botox-A) on Experimentally Induced Cutaneous Pain in Healthy Subjects
ClinicalTrials.gov Identifier: NCT00435682 - Recruiting
Healthy
- Efficacy and Safety of TF002 in Cutaneous Mastocytosis
ClinicalTrials.gov Identifier: NCT00457288 - Completed
Cutaneous Mastocytosis
- Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00306969 - Completed
Cutaneous T-Cell Lymphoma
- Study of ONTAK (denileukin diftitox) in Previously Treated Cutaneous T-cell Lymphoma Patients
ClinicalTrials.gov Identifier: NCT00051012 - Completed
Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Sezary Syndrome
- Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00006345 - Completed
Drug Toxicity; recurrent cutaneous T-cell lymphoma; recurrent mycosis fungoides/Sezary syndrome
- Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV
ClinicalTrials.gov Identifier: NCT00027339 - Active, not recruiting
HIV Infections
- Effects of Antibodies to White Blood Cells on Platelet Transfusion Patients
ClinicalTrials.gov Identifier: NCT00460122 - Recruiting
Healthy; Transfusion Reactions
- Study of ONTAK (denileukin diftitox) in Cutaneous T-cell Lymphoma (CTCL) Patients
ClinicalTrials.gov Identifier: NCT00050999 - Completed
Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Sezary Syndrome
- Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood Donations
ClinicalTrials.gov Identifier: NCT00302900 - Recruiting
Syncope, Vasovagal
- Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)
ClinicalTrials.gov Identifier: NCT00317681 - Completed
Cutaneous Lupus Erythematosus
- Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
ClinicalTrials.gov Identifier: NCT00438659 - Active, not recruiting
Breast Cancer; Dermatologic Complications; Radiation Toxicity; Skin Reactions Secondary to Radiation Therapy
- Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL
ClinicalTrials.gov Identifier: NCT00178841 - Completed
Cutaneous T-Cell Lymphoma; Mycosis Fungoides; Sezary Syndrome
- Duke Lupus Registry
ClinicalTrials.gov Identifier: NCT00512694 - Recruiting
Systemic Lupus Erythematosus; Cutaneous Lupus
- Use of 852A in Metastatic Cutaneous Melanoma.
ClinicalTrials.gov Identifier: NCT00189332 - Completed
Melanoma; Unresectable Metatstatic Cutaneous Melanoma
- Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00394693 - Recruiting
Lymphoma, B-Cell
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
